Patentica at APAA 2024

8 месяцев ago

Olga Gribanova and Eduard Shablin of Patentica were in attendance at the 76th Asian Patent Attorneys Association Council Meeting (APAA…

Tracking deadlines is an essential aspect of patent prosecution

8 месяцев ago

Dear colleagues, we would like to inform you about the weekends and holidays in 2025 that will impact the workflow…

October 24-26, 2024 | Patentica took part in AIPLA 2024 Annual Meeting

8 месяцев ago

Maria Nilova and Nikolai Kovkov from Patentica recently participated in the AIPLA 2024 Annual Meeting at the Gaylord National Resort…

Patentica participated in the LES USA-Canada Annual Meeting | October 20-23, 2024

9 месяцев ago

Maria Nilova and Nikolai Kovkov from Patentica recently took part in the LES USA-Canada Annual Meeting from October 20 to…

4,667 intellectual property infringements were identified in the EAEU in 2023

9 месяцев ago

On October 9, a meeting of the Advisory Committee on Intellectual Property under the Board of the Eurasian Economic Commission…

Rospatent’s clarifications on the Statute on Fees as amended

9 месяцев ago

The Russian Patent and Trademark Office has issued clarifications regarding some typical questions on the new Statute on Fees, effective…

Revocation of Patent RU 2421238 Related to Liraglutide Composition (Sun Pharmaceuticals Industries, Ltd (IN) v. Novo Nordisk A/S (DK))

9 месяцев ago

Patentica’s patent attorneys, Victor Lisovenko and Ksenia Emelianova have successfully represented Sun Pharmaceuticals in opposing Novo Nordisk’s patent RU 2421238.…

Patent fees in Russia will undergo changes starting from October 5, 2024

9 месяцев ago

Starting October 5, 2024, significant changes will take effect in Russia’s patent fee structure, following Resolution No. 1278 of September…

Roskomnadzor has removed over 300 million links to pirated content from search results in Russia

10 месяцев ago

During the industry conference "Book Market of Russia - 2024" at the Moscow International Book Fair, Evgeny Zaitsev, the head…

AstraZeneca has challenged the Eurasian patent for an analogue of its cancer drug Tagrisso in Russia

10 месяцев ago

On August 8, 2024, the Patent Disputes Chamber of Rospatent upheld AstraZeneca’s objection to the validity of the Eurasian Patent…